# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Apr 27, 2016

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2016-04-27
- Accepted by EDGAR: Apr 27, 2016, 20:13 ET
- Period: 2016-04-26
- Accession: 0000875320-16-000070
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532016000070/a8-kq12016.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532016000070/

## Items reported

- Item 2.02: Results of operations
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532016000070/a8-kq12016.htm

Filed Apr 27, 2016.
Source: SEC EDGAR, the filing index for accession 0000875320-16-000070. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.
